Home/Pipeline/Exablate Platform

Exablate Platform

Uterine Fibroids

CE MarkedActive

Key Facts

Indication
Uterine Fibroids
Phase
CE Marked
Status
Active
Company

About Insightec

Insightec is a commercial-stage medical device company that has developed and markets the Exablate Neuro platform, an MR-guided focused ultrasound system for the non-invasive treatment of neurological movement disorders. The company's technology represents a significant innovation in neurosurgery, offering a precise, incisionless procedure with immediate therapeutic effect and minimal complications, allowing patients to typically return home the same day. Founded in 1999 and headquartered in Miami, Florida, Insightec is a private company that has established a commercial footprint for its FDA-approved system in treatment centers worldwide. Its core value proposition is transforming patient care by providing a non-invasive alternative to traditional brain surgery for tremor conditions.

View full company profile

About Insightec

Insightec is a commercial-stage medical device company that has developed and markets the Exablate Neuro platform, an MR-guided focused ultrasound system for the non-invasive treatment of neurological movement disorders. The company's technology represents a significant innovation in neurosurgery, offering a precise, incisionless procedure with immediate therapeutic effect and minimal complications, allowing patients to typically return home the same day. Founded in 1999 and headquartered in Miami, Florida, Insightec is a private company that has established a commercial footprint for its FDA-approved system in treatment centers worldwide. Its core value proposition is transforming patient care by providing a non-invasive alternative to traditional brain surgery for tremor conditions.

View full company profile

About Insightec

Insightec is a commercial-stage medical device company that has developed and markets the Exablate Neuro platform, an MR-guided focused ultrasound system for the non-invasive treatment of neurological movement disorders. The company's technology represents a significant innovation in neurosurgery, offering a precise, incisionless procedure with immediate therapeutic effect and minimal complications, allowing patients to typically return home the same day. Founded in 1999 and headquartered in Miami, Florida, Insightec is a private company that has established a commercial footprint for its FDA-approved system in treatment centers worldwide. Its core value proposition is transforming patient care by providing a non-invasive alternative to traditional brain surgery for tremor conditions.

View full company profile

About Insightec

Insightec is a commercial-stage medical device company that has developed and markets the Exablate Neuro platform, an MR-guided focused ultrasound system for the non-invasive treatment of neurological movement disorders. The company's technology represents a significant innovation in neurosurgery, offering a precise, incisionless procedure with immediate therapeutic effect and minimal complications, allowing patients to typically return home the same day. Founded in 1999 and headquartered in Miami, Florida, Insightec is a private company that has established a commercial footprint for its FDA-approved system in treatment centers worldwide. Its core value proposition is transforming patient care by providing a non-invasive alternative to traditional brain surgery for tremor conditions.

View full company profile

Other Uterine Fibroids Drugs

DrugCompanyPhase
GYIDENesa MedtechPreclinical
Menstrual Blood Biomarker DiscoveryQvinResearch
HeatSYNC for Uterine FibroidsTheromicsPre-clinical
Sonalleve®Profound MedicalCommercial